Literature DB >> 13446468

Clinical experience with tolbutamide.

G WALKER, J D SLATER, E K WESTLAKE, J D NABARRO.   

Abstract

Entities:  

Keywords:  DIABETES MELLITUS/therapy; SULFONAMIDES/therapeutic use; UREA/related compounds

Mesh：

Substances：

Year:  1957        PMID： 13446468      PMCID： PMC1961998          DOI： 10.1136/bmj.2.5040.323

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  5 in total

1.  Hypoglycaemic sulphonamides in treatment of diabetes.

Authors:  G WALKER; W L LEESE; J D NABARRO
Journal:  Br Med J       Date:  1956-08-25

2.  [A new anti-diabetes principle; results of clinical research].

Authors:  H FRANKE; J FUCHS
Journal:  Dtsch Med Wochenschr       Date:  1955-10-07       Impact factor: 0.628

3.  Metabolic effects of arylsulfonylurea compounds in normal men and in diabetic subjects.

Authors:  I P ACKERMAN; J W CONN; S S FAJANS; R D GITTLER; A R HENNES; R D JOHNSON; L H LOUIS; H S SELTZER; B L WAJCHENBERG
Journal:  Metabolism       Date:  1956-11       Impact factor: 8.694

4.  Extractable insulin of the pancreas and effectiveness of oral hypoglycaemic sulfonylureas in the treatment of diabetes in man; a comparison.

Authors:  G A WRENSHALL; C H BEST
Journal:  Can Med Assoc J       Date:  1956-06-15       Impact factor: 8.262

5.  Body weight at different ages and heights.

Authors:  W F F KEMSLEY
Journal:  Ann Eugen       Date:  1952-05
  5 in total
  2 in total

1.  Oral hypoglycaemic drugs.

Authors:  J D SLATER
Journal:  Postgrad Med J       Date:  1959-05       Impact factor: 2.401

2.  Clinical experience with chlorpro-pamide.

Authors:  G WALKER; L W KINSELL
Journal:  Calif Med       Date:  1961-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.